Marc Beer has extensive experience and expertise in commercialization and development in pharmaceuticals, diagnostics, devices, and biotechnology. Marc Beer cofounded Revonia alongside Yolanda Lorie, MD, and Ramon Iglesias in August 2016. The company has successfully achieved a Series A Financing with top healthcare business capital funds since its creation in 2016.
Marc Beer was appointed the Founding Chief Executive Officer of ViaCell in April 2010. ViaCell is a biotechnology firm that focuses on the activities that are involved in the collection, preservation, and development of blood stem cells of the human umbilical cord. Marc Beer led the management of ViaCell for over seven years. He helped the company to grow from its inception to become one of the rapidly growing firms with the intense commercialization of its products and services.
Marc Beer’s leadership and management of ViaCell helped it to go public in 2005, developed to offer over 300 job opportunities, and later purchased by PerkinElmer in the year 2007. Marc Beer dedicated his time and skills to ensure that he used his position as the CEO of the ViaCell to propel it from its humble beginning to attaining international standards.
Marc Beer was also a Board member of the Board of Directors of Erytech Pharma. Erytech Pharma is a publicly traded company that provides pharmaceutical products and services. He was key personnel in the board as he represented the firm in a variety of development forums. Marc Beer also held a variety of positions in Genzyme. One of the most recent post that Mr. Marc held within Genzyme was that of the Vice President of Global Marketing. Under this rank, Mr. Marc Beer was tasked with the responsibilities of the commercial launching of various products that addressed several rare diseases that affected populations around the globe.
Before joining Genzyme, Marc spent years serving Abbott Laboratories where he held various roles in sales and marketing in the diagnostic and pharmaceutical divisions. Marc was also in the Mass Life Science Board of the Massachusetts Commonwealth. He worked in the Emerging Companies Section Governing Board of the Biotechnology Industry Organization.
Marc Beer was among the founders and Founding Chairman of the Board of directors of Good Start Genetics, Inc. He was also the Chairman of the compensation committee of the organization. The Good Start Genetics, Inc. was purchased by InVatae Company just recently. Marc Beer also played some vital roles in the foundation of Minerva Neurosciences, Inc. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer